Cargando…
The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model
The combination of plant-derived compounds with anti-diabetic agents to manage hepatic steatosis closely associated with diabetes mellitus may be a new therapeutic approach. Silymarin, a complex of bioactive substances extracted from Silybum marianum, evinces an antioxidative, anti-inflammatory, and...
Autores principales: | Hüttl, Martina, Markova, Irena, Miklankova, Denisa, Zapletalova, Iveta, Poruba, Martin, Racova, Zuzana, Vecera, Rostislav, Malinska, Hana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780287/ https://www.ncbi.nlm.nih.gov/pubmed/35056941 http://dx.doi.org/10.3390/pharmaceutics14010045 |
Ejemplares similares
-
Beneficial Effect of Fenofibrate and Silymarin on Hepatic Steatosis and Gene Expression of Lipogenic and Cytochrome P450 Enzymes in Non-Obese Hereditary Hypertriglyceridemic Rats
por: Vecera, Rostislav, et al.
Publicado: (2022) -
Metformin Affects Cardiac Arachidonic Acid Metabolism and Cardiac Lipid Metabolite Storage in a Prediabetic Rat Model
por: Miklankova, Denisa, et al.
Publicado: (2021) -
Beneficial effects of troxerutin on metabolic disorders in non-obese model of metabolic syndrome
por: Malinska, Hana, et al.
Publicado: (2019) -
Ovariectomy-Induced Hepatic Lipid and Cytochrome P450 Dysmetabolism Precedes Serum Dyslipidemia
por: Malinská, Hana, et al.
Publicado: (2021) -
In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia
por: Hüttl, Martina, et al.
Publicado: (2021)